Laurion Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-116,600	Closed	-$1.05M	–	962
2020 Q3	$1.05M	Buy	+116,600	New	+$1.23M	0.01%	416
2019 Q4	–	Sell	-269,100	Closed	-$2.4M	–	1221
2019 Q3	$1.85M	Buy	269,100 +162,300	+152%	+$1.24M	0.01%	511
2019 Q2	$986K	Buy	+106,800	New	+$1.29M	0.01%	573
2019 Q1	–	Sell	-12,818	Closed	-$198K	–	1276
2018 Q4	$198K	Buy	12,818 +10,700	+505%	+$219K	﹤0.01%	970
2018 Q3	$46K	Sell	2,118 -5,050	-70%	-$117K	﹤0.01%	1119
2018 Q2	$174K	Sell	7,168 -8,050	-53%	-$164K	﹤0.01%	1216
2018 Q1	$260K	Sell	15,218 -167,000	-92%	-$3.26M	﹤0.01%	1169
2017 Q4	$3.45M	Buy	182,218 +19,129	+12%	+$288K	0.02%	629
2017 Q3	$2.87M	Buy	+163,089	New	+$3.67M	0.01%	661
2017 Q2	–	Sell	-107,579	Closed	-$3.33M	–	1859
2017 Q1	$3.45M	Buy	107,579 +48,474	+82%	+$1.65M	0.03%	501
2016 Q4	$2.14M	Sell	59,105 -828,164	-93%	-$33.1M	0.02%	556
2016 Q3	$40.8M	Buy	887,269 +460,559	+108%	+$24M	0.38%	56
2016 Q2	$21.4M	Sell	426,710 -40,883	-9%	-$2.18M	0.34%	74
2016 Q1	$25M	Buy	467,593 +160,952	+52%	+$9.44M	0.39%	65
2015 Q4	$20.1M	Buy	306,641 +262,941	+602%	+$16.2M	0.19%	108
2015 Q3	$2.47M	Buy	+43,700	New	+$2.83M	0.03%	309